Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

(2014) Daniel J. Klionsky et al.   Autophagy

Inhibition of MCL-1 enhances Lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy

(2010) Aditi Pandya Martin et al.   CANCER BIOLOGY & THERAPY

Mechanism of Autophagy to Apoptosis Switch Triggered in Prostate Cancer Cells by Antitumor Cytokine Melanoma Differentiation-Associated Gene 7/Interleukin-24

(2010) Sujit K. Bhutia et al.   CANCER RESEARCH

Platonin induces autophagy-associated cell death in human leukemia cells

(2009) Yu-Jen Chen et al.   Autophagy

Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line

(2009) Pascal Colosetti et al.   Autophagy

Coordinate regulation of autophagy and apoptosis in T cells by death effectors: FADD or foundation

(2009) Bryan D. Bell et al.   Autophagy

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

(2009) Ramesh K. Ramanathan et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib

(2009) Kohji Noguchi et al.   CANCER SCIENCE

RIP Kinases at the Crossroads of Cell Death and Survival

(2009) Wim Declercq et al.   CELL

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

(2009) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas

(2009) T. Bekaii-Saab et al.   CLINICAL CANCER RESEARCH

A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy via Regulating Beclin 1

(2009) Jianrong Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines

(2009) K A Olaussen et al.   ONCOGENE

Lapatinib: A Sword With Two Edges

(2009) László Kopper   PATHOLOGY & ONCOLOGY RESEARCH

Oral small-molecule tyrosine kinase inhibitor midostaurin (PKC412) inhibits growth and induces megakaryocytic differentiation in human leukemia cells

(2009) Yu-Chuen Huang et al.   TOXICOLOGY IN VITRO

Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison

(2008) Simone Boehrer et al.   BIOCHEMICAL PHARMACOLOGY

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

(2008) G Kroemer et al.   CELL DEATH AND DIFFERENTIATION

Erlotinib in a Patient With Acute Myelogenous Leukemia and Concomitant Non–Small-Cell Lung Cancer

(2008) Vincenzo Pitini et al.   JOURNAL OF CLINICAL ONCOLOGY

Gefitinib potentiates myeloid cell differentiation by ATRA

(2008) M B Miranda et al.   LEUKEMIA

Bcr-Abl induces autocrine IGF-1 signaling

(2008) A Lakshmikuttyamma et al.   ONCOGENE